(Reuters) - Europe's STOXX 600 opened lower on Friday, dragged by technology and healthcare stocks, keeping the index on ...

Shares in major pharmaceutical companies also dipped. For example: Eli Lilly shares fell 4.9 percent Pfizer 4.5 percent Amgen nearly 4.3 percent Novo Nordisk 3.4 percent The announcement sparked alarm ...

When the healthcare sector sneezes, European investors catch a cold. Healthcare is the single biggest sector in the Stoxx ...

↘️ Applied Materials (AMAT): Shares fell 8% after the semiconductor-equipment company posted a weaker-than-expected sales ...

The company's revenue jumped 77% in Q3 to reach $401.6 million in Q3 2024, alongside a net income of $75.6 million. It now ...

Polen Capital, an investment management company, released its “Polen Global Growth Strategy” third-quarter 2024 investor ...

AstraZeneca and Amgen announced that a Phase 3 trial of Tezspire (tezepelumab) showed a statistically significant and ...

It’s been a year since the gene-editing treatment Casgevy was approved for sickle cell disease and a related blood disorder.

In case you’ve missed it, ASX COVID-era tech darling Bigtincan Holdings (ASX:BTH) has received a takeover offer from the ...

NEW YORK (Reuters) -President-elect Donald Trump said on Thursday he has selected Robert F. Kennedy Jr., an environmental ...

Plus: How AI can make it easier to find drugs from nature and a study suggests Ozempic could treat alcoholism.